PreDxion Bio
YC S17San Francisco, US · Founded 2017 · 6 employees · Inactive · 1 known investors
PreDxion Bio develops rapid diagnostic tests using saliva samples and a scalable semiconductor-based platform, initially targeting SARS-CoV-2 detection for asymptomatic and presymptomatic individuals, with broader applications in monitoring immune response markers in critically ill patients and predicting complications from cell therapies.
Founders & leadership· Y Combinator alumni (S17)
Walker McHughin𝕏Founder
Timothy CornellinFounder